Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HTR1B | P28222 | 2/20 | 0.32 |
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | BAX | Q07812 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8347164 | 1.00 | CA4 (0.43) | CA4LTA4HTSHRKCNA3TRPA1 | |
| SCHEMBL5898125 | 1.00 | CA4 (0.43) | CA4LTA4HTSHRKCNA3TRPA1 | |
| Ammonia Solution, Strong SCHEMBL30411567 | 0.97 | CA4 (0.42) | CA4LTA4HTSHRKCNA3TRPA1 | |
| SCHEMBL5207997 | 0.91 | LTA4H (0.52) | LTA4HTSHRLMNANR1H2BAX | |
| Ethylene Glycol SCHEMBL5047766 | 0.89 | ALDH1A1 (0.43) | CA4LTA4HTSHRKCNA3CA5A | |
| Sulfuric Acid SCHEMBL21110867 | 0.87 | CA1 (0.38) | CA4TSHRLMNAKMT2A | |
| Phosphoric Acid SCHEMBL21144483 | 0.87 | SRC (0.47) | CA4TSHRCA5A | |
| SCHEMBL16807837 | 0.86 | CYP1A2 (0.40) | LMNACHRNB2CHRNA4GAA | |
| SCHEMBL5612605 | 0.86 | LMNA (0.39) | TSHRLMNACHRNB2CHRNA4 | |
| Sulfuric Acid SCHEMBL21111048 | 0.85 | CA1 (0.36) | CA4TSHRLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2002536440-A | — | — | 2002-10-29 | — | — | JP | claimed |
| EP-1155007-A2 | 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES | G.D. Searle LLC (US) | 2001-11-21 | — | — | EP | claimed |
| WO-2000047568-A2 | 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES | G.D. SEARLE LLC (US) | 2000-08-17 | — | — | WO | claimed |
| JP-61034082-A | — | — | None | — | — | JP | disclosed |
| CN-115073661-A | Resin composition and display device using same | 三星显示有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-112831278-A | Photocurable resin composition | ＫＣＣ公司 | 2021-05-25 | — | — | CN | disclosed |
| US-9839690-B2 | Singlet oxygen-labile linkers and methods of production and use thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2017-12-12 | — | — | US | disclosed |
| US-20170014510-A1 | Singlet Oxygen-Labile Linkers and Methods of Production and Use Thereof | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2017-01-19 | — | — | US | disclosed |
| EP-3106488-A1 | PHOTOBASE-CATALYSED OXIDATIVE POLYMERISATION OF POLY (DISULPHIDE)S | Université de Haute Alsace (FR) | 2016-12-21 | — | — | EP | disclosed |
| US-9393306-B2 | Singlet oxygen-labile linkers and methods of production and use thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150165026-A1 | SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2015-06-18 | — | — | US | disclosed |
| WO-2003061604-A2 | NOVEL ALKYL/ARYL HYDROXY OR KETO THIEPINES. | PHARMACIA CORPORATION (US) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003040127-A1 | NOVEL MONO- AND DI-FLUORINATED BENZOTHIEPINE COMPOUNDS AS INHIBITORS OF APICAL SODIUM CO-DEPENDENT BILE ACID TRANSPORT (ASBT) AND TAUROCHOLATE UPTAKE | G.D. SEARLE LLC (US) | 2003-05-15 | — | — | WO | disclosed |
| EP-1155007-A2 | 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES | G.D. Searle LLC (US) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000047568-A2 | 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES | G.D. SEARLE LLC (US) | 2000-08-17 | — | — | WO | disclosed |
| US-5264545-A | Aromatic or partly aromatic diamine with tetracarboxylic acid | BASF LACKE+FARBEN AKTIENGESELLSCHAFT (DE) | 1993-11-23 | — | — | US | disclosed |
| US-4652405-A | Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol | HOFFMAN-LA ROCHE INC. (US) | 1987-03-24 | — | — | US | disclosed |
| US-4634692-A | OSTEOPOROSIS | HOFFMANN-LA ROCHE INC. (US) | 1987-01-06 | — | — | US | disclosed |
| JP-S6134082-A | LOWLY ODOROUS TWO-PACK ACRYLIC ADHESIVE HAVING EXCELLENT ADHESION | OKURA IND CO LTD | 1986-02-18 | — | — | JP | disclosed |
| US-3993684-A | PHOTOSENSITIVE ACRYLIC ESTER POLYMERS | WESTERN LITHO PLATE & SUPPLY CO. (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014510-A1 | Singlet Oxygen-Labile Linkers and Methods of Production and Use Thereof | PPOX, DUOX1, PAICS | CA4 687/4885LTA4H 500/4885TSHR 4467/4885 |
| US-20150165026-A1 | SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF | PPOX, DUOX1, PAICS | CA4 687/4885LTA4H 500/4885TSHR 4467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.